Optimizing statin therapy in HIV-infected patients: a review of pharmacotherapy considerations
{{output}}
Background: People living with HIV (PLWH) are more vulnerable to cerebrovascular disease, including coronary artery disease. Dyslipidemia is a risk factor for major adverse cardiovascular events in this population as a whole. Dys... ...
